J, C., M, V., S, N., G, S., S, M., I, S., . . . RT, M. (2026). Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity. Science (New York, N.Y.), 392(6794), eady5196. https://doi.org/10.1126/science.ady5196
Chicago Style (17th ed.) CitationJ, Chung, et al. "Sialylated CD43 Forms a Glyco-immune Barrier That Restrains Antileukemic Immunity." Science (New York, N.Y.) 392, no. 6794 (2026): eady5196. https://doi.org/10.1126/science.ady5196.
MLA (9th ed.) CitationJ, Chung, et al. "Sialylated CD43 Forms a Glyco-immune Barrier That Restrains Antileukemic Immunity." Science (New York, N.Y.), vol. 392, no. 6794, 2026, p. eady5196, https://doi.org/10.1126/science.ady5196.
Warning: These citations may not always be 100% accurate.